StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Concerns Around CVS Health (CVS) Accelerated PBM Losses Likely Overblown - Cantor Fitzgerald
March 27, 2019 11:08 AM
Cantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $80.00 price target on CVS Health (NYSE: CVS) saying concerns ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
March 28, 2019 7:07 AM
CVS Health (CVS) Falls Following Centene/WellCare Merger
March 27, 2019 8:12 AM